News and Publications?height=270

News & publications

Related news & insights - Arran Macleod

Prostate Cancer Awareness Month – new treatment for 9,000 NHS patients
Posted: 30/11/2022
As we near the end of Movember, the aim of which is to raise awareness of prostate cancer, it has been announced that about 9,000 NHS patients in England with advanced prostate cancer will be eligible to receive an innovative new treatment that will increase their chances of survival......>>
Diabetic retinopathy – how eye disease can result from diabetes
Posted: 17/11/2022
Monday 14 November 2022 was World Diabetes Day. Diabetes can have various health consequences, one of which is known as diabetic retinopathy. Diabetic retinopathy can impair a person’s sight, lead to glaucoma, or even total blindness, and is one of the most common causes of blindness in people of a working age......>>
Prostate Cancer Awareness Month 2022 – why early detection can be the difference between life and death
Posted: 01/11/2022
Globally, 1.4 million men are diagnosed with prostate cancer each year. Across the UK, it is the most commonly diagnosed cancer and more than 395,000 men are currently living with the disease. Over 52,000 men are diagnosed here annually, and 12,000 men will die. One in eight men will get prostate cancer during their lifetime......>>
World Sight Day 2022 – focusing on the importance of regular sight test appointments
Posted: 13/10/2022
Over 2.2 billion people worldwide suffer from visual impairment and, sadly, almost half of those visual impairments could have been prevented or avoided. Thursday 13 October is World Sight Day. The charity responsible for the annual campaign, the International Agency for the Prevention of Blindness (IAPB), this year focuses on the importance of......>>
National cancer screening programme extended to include lung cancer
Posted: 07/10/2022
Following new guidance from the UK National Screening Committee (UKNSC), the national cancer screening programme — which already tests for breast, cervix and bowel cancer — is to be extended to include testing for lung cancer......>>
Reusable contact lenses ‘raise risk of eye infection’
Posted: 28/09/2022
Recent research conducted by teams at the University College London and Moorfields Eye Hospital have found that wearers of reusable contact lenses are almost four times as likely to develop a sight-threatening eye infection, when compared with those who use daily disposable contact lenses......>>
Prostate cancer – tackling common perceptions to ensure early diagnosis
Posted: 16/08/2022
Each year, up to 100,000 men are suspected of having prostate cancer. Over 52,000 men are diagnosed, and 12,000 men die from the disease. It is the most common type of cancer in men; one in eight will get prostate cancer during their lifetime, and the risk is higher for men over 50, black men, or if there is a family history of the disease......>>
Screening for prostate cancer could be possible within five years
Posted: 14/01/2022
On average, around 50,000 men in the UK are diagnosed with prostate cancer each year, resulting in the death of approximately 12,000 men annually. Prostate cancer is responsible for more deaths than breast cancer; by 2030, it is forecast to be the most common cancer in the UK......>>
World Sight Day: focussing on the causes of sight loss
Posted: 14/10/2021
This article is one of a series of articles in support of World Sight Day and focusses on optic neuropathy, one of the most serious injuries experienced by patients that results in sight loss. The optic nerve transports signals from the eye to the brain, which then changes the signals into images......>>
Researchers warn that ‘Covid disruption will affect millions’ for years to come
Posted: 15/07/2021
As we move out of Covid restrictions, with full easing of rules in England and Wales from 19 July 2021, researchers have started to look back at how Covid-19 has impacted health services that are not directly linked to the pandemic......>>

1
2
3
4

Filter news & insights

Filter by keyword: Filter by expertise:

In this section

Media enquiries

Contact our press team on:

+44 (0)20 7457 3258
+44 (0)7887 888105 (out of hours)

Useful links

Value

Contact an office

London (Head office)
+44 (0)20 7457 3000
London (Minories)
+44 (0)20 7481 8851
Basingstoke
+44 (0)1256 407100
Birmingham
+44 (0)121 312 2560
Cambridge
+44 (0)1223 465465
Guildford
+44 (0)1483 791800
Oxford
+44 (0)1865 722106
Reading
+44 (0)118 982 2640

Madrid
+34 91 781 6670
Paris
+33 1 44 34 24 80
Piraeus
+30 210 361 4840
Singapore
+65 6438 4497

Sectors

Services for Business

Services for Individuals

Copyright

© 2023 Penningtons Manches Cooper LLP.
All rights reserved.
Website design by Frontmedia / Dynamic Pear

Penningtons Manches Cooper LLP

Penningtons Manches Cooper LLP is a limited liability partnership registered in England and Wales with registered number OC311575 and is authorised and regulated by the Solicitors Regulation Authority.